Corona Updates You Must Track: Nearly 98,000 COVID-19 Cases In 24 Hours, Serum Institute To Resume Trials For Oxford Vaccine
Nearly 33 per cent Delhi residents may have been exposed to the virus, as per the early findings of the third sero-survey in the capital. Global COVID-19 tally has breached the 30-million mark
India cases and toll: India added a record 97,894 cases of coronavirus in 24 hours, from 8 am Wednesday to 8 am Thursday. With this, the country’s coronavirus tally has gone up to 51,18,253. India’s active caseload crossed the 10-lakh mark and the number of currently infected patients now stands at 10,09,976, as per the data shared by the Ministry of Health and Family Welfare.
A total of 40,25,079 people have recovered from the illness; the recovery rate for COVID-19 is 78.64 per cent. In the last 24 hours, 1,132 people succumbed to the disease, taking the overall toll to 83,198. India conducted 11,36,613 tests for COVID-19 on Wednesday.
Serum Institute gets nod to resume trials for Oxford vaccine: Close on the heels of the pharma major AstraZeneca resuming the clinical trials of its experimental COVID-19 vaccine, jointly developed with Oxford University, Serum Institute has also got the clearance from the Drugs Controller General of India (DFCI) to resume the trials in India.
A week ago, the Pune-based Serum Institute of India was served a notice by the DGCI after AstraZeneca had halted the global trials of the vaccine over a suspected illness in a trial candidate. Serum Institute has partnered with AstraZeneca to manufacture the vaccine doses for low- and middle-income countries.
33% Delhi residents exposed to COVID-19: As per the initial findings of the third sero-survey in Delhi, nearly 33 per cent of the residents in the national capital could have been exposed to COVID-19. In other words, roughly 66 lakh Delhiites (of the 2 crore population) may have developed antibodies against the virus.
The survey conducted in the first week of September collected 17,000 samples, and the report is being reviewed by the health department. In the first sero-survey, conducted between June-end and early July, antibodies against the virus were found in nearly 23 per cent sam...
India cases and toll: India added a record 97,894 cases of coronavirus in 24 hours, from 8 am Wednesday to 8 am Thursday. With this, the country’s coronavirus tally has gone up to 51,18,253. India’s active caseload crossed the 10-lakh mark and the number of currently infected patients now stands at 10,09,976, as per the data shared by the Ministry of Health and Family Welfare.
A total of 40,25,079 people have recovered from the illness; the recovery rate for COVID-19 is 78.64 per cent. In the last 24 hours, 1,132 people succumbed to the disease, taking the overall toll to 83,198. India conducted 11,36,613 tests for COVID-19 on Wednesday.
Serum Institute gets nod to resume trials for Oxford vaccine: Close on the heels of the pharma major AstraZeneca resuming the clinical trials of its experimental COVID-19 vaccine, jointly developed with Oxford University, Serum Institute has also got the clearance from the Drugs Controller General of India (DFCI) to resume the trials in India.
A week ago, the Pune-based Serum Institute of India was served a notice by the DGCI after AstraZeneca had halted the global trials of the vaccine over a suspected illness in a trial candidate. Serum Institute has partnered with AstraZeneca to manufacture the vaccine doses for low- and middle-income countries.
33% Delhi residents exposed to COVID-19: As per the initial findings of the third sero-survey in Delhi, nearly 33 per cent of the residents in the national capital could have been exposed to COVID-19. In other words, roughly 66 lakh Delhiites (of the 2 crore population) may have developed antibodies against the virus.
The survey conducted in the first week of September collected 17,000 samples, and the report is being reviewed by the health department. In the first sero-survey, conducted between June-end and early July, antibodies against the virus were found in nearly 23 per cent samples. This number rose to 29.1 per cent in the second sero-survey in the first week of August.
Asymptomatic migrant workers can work in Kerala: Migrant workers in Kerala who have tested positive for COVID-19 but are asymptomatic can continue working, but in exclusively-marked areas with all precautions in place. As per the state government order issued on 14 September, if such asymptomatic, COVID-19 positive workers develop any symptoms, like fever, sore throat or loss of smell, they should be immediately referred to a COVID-designated hospital.
Global corona update: The global coronavirus tally breached the 30-million or 3-crore mark on Thursday morning, as per the data available on Worldometer, which tracks COVID-19 cases real-time. The total global caseload is 3,00,42,299 with 72,88,726 active cases, 2,18,08,409 recoveries and 9,45,164 deaths. Of the active cases, 61,244 are in critical or serious condition.
Starting October, Thailand, a popular tourist destination, will issue special visas to foreign tourists who are planning a long stay in the country. The visa will be issued for 90 days and can be renewed for another 90 days twice. Foreign tourists will have to undergo 14-day quarantine at state quarantine facilities or hospitals.